Algernon Pharmaceuticals Inc (AGNPF)

[bettingonbayst]

Thanks kotato for your speculation. I sure hope you are wrong as that would be the Weasleist thing a management team could do, but in penny stocks, anything could happen.

I however think it has more to do with their CRO than anything else, which leads to more questions:

What is Novotech's role in this 2b/trial?

Can Novotech assist/take part in the trial's taking place in Canada and the United States?

....

We know that South Korea is an "investigator lead study" lead by Algernon's CRO Novotech. We have also been told that the 2b/3 multinational trail is company lead, so lead by Algernon (Chris and Mark?).

With Novotech being an Australian company that covers South East Asia, are they able to assist in North America as well?

Is it possible that Algernon is trying to recruit as many patients as possible in countries Novotech operates in the further use their resources and expertise?

Maybe I'm getting way off base here, but I feel we aren't being told the whole story.

B. O. B.